Jefferies initiated coverage of Medline Inc. (NASDAQ:MDLN) with a “buy” rating in a note dated Monday, citing the company’s ...

Deployment of Ranpak’s automation solutions boosts efficiency and reduces material use for the largest provider of ...

Ranpak expands automation in healthcare distribution with Medline, optimizing packaging efficiency and sustainability.

Shares of Medline were up 5.4% as markets closed Monday, adding to gains since its initial public offering, which was the ...

Investing.com -- Wall Street analysts initiated coverage on Medline Industries, pointing to high visibility on revenue growth ...

Most Wall Street firms start coverage with buy ratings, citing scale, vertical integration, and long-term healthcare demand.

Ranpak announced a partnership with Medline Industries, the largest provider of medical-surgical products and supply chain solutions.

Medline is now on Nasdaq. Medline raised $6.26 billion in the largest US IPO since 2021. Overwhelming demand led to an upsized offering of 216 million shares. Medline offers 190,000 products, 43,000 ...

The upgrade reflects Medline’s significant debt reduction of $4.0 billion using IPO proceeds, which Fitch expects will lower the company’s EBITDA leverage to approximately 3.5x over the medium term.

NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are ...

Recent Medline moves include new vendor agreements and an IPO, strengthening supply chain ties with major health systems.